CN101695354A - 一种预消化的大豆食品 - Google Patents
一种预消化的大豆食品 Download PDFInfo
- Publication number
- CN101695354A CN101695354A CN200910210746A CN200910210746A CN101695354A CN 101695354 A CN101695354 A CN 101695354A CN 200910210746 A CN200910210746 A CN 200910210746A CN 200910210746 A CN200910210746 A CN 200910210746A CN 101695354 A CN101695354 A CN 101695354A
- Authority
- CN
- China
- Prior art keywords
- soybean
- food
- fermentation
- predigested
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013597 soy food Nutrition 0.000 title claims abstract description 55
- 238000000855 fermentation Methods 0.000 claims abstract description 53
- 230000004151 fermentation Effects 0.000 claims abstract description 53
- 235000013305 food Nutrition 0.000 claims abstract description 34
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 10
- 235000013376 functional food Nutrition 0.000 claims abstract description 8
- 235000015097 nutrients Nutrition 0.000 claims abstract description 7
- 208000011580 syndromic disease Diseases 0.000 claims abstract description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 117
- 244000068988 Glycine max Species 0.000 claims description 114
- 230000000694 effects Effects 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 239000011159 matrix material Substances 0.000 claims description 17
- 238000005213 imbibition Methods 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 15
- 238000008214 LDL Cholesterol Methods 0.000 claims description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 10
- 235000008696 isoflavones Nutrition 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 9
- 235000014633 carbohydrates Nutrition 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 9
- 238000009461 vacuum packaging Methods 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 8
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 8
- 235000019626 lipase activity Nutrition 0.000 claims description 8
- 238000011081 inoculation Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 235000008085 high protein diet Nutrition 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 229920001542 oligosaccharide Polymers 0.000 claims description 6
- 150000002482 oligosaccharides Chemical class 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 5
- 238000007605 air drying Methods 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 150000004665 fatty acids Chemical class 0.000 claims description 5
- 230000009467 reduction Effects 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000002054 inoculum Substances 0.000 claims description 4
- 235000021419 vinegar Nutrition 0.000 claims description 4
- 239000000052 vinegar Substances 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 229930182478 glucoside Natural products 0.000 claims description 2
- 150000008131 glucosides Chemical class 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 230000035764 nutrition Effects 0.000 claims description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 17
- 235000012000 cholesterol Nutrition 0.000 abstract description 10
- 108091005804 Peptidases Proteins 0.000 abstract description 4
- 239000004365 Protease Substances 0.000 abstract description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 4
- 102000004882 Lipase Human genes 0.000 abstract description 3
- 108090001060 Lipase Proteins 0.000 abstract description 3
- 239000004367 Lipase Substances 0.000 abstract description 3
- 235000019421 lipase Nutrition 0.000 abstract description 3
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 241000235527 Rhizopus Species 0.000 abstract 1
- 230000009245 menopause Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 74
- 238000002474 experimental method Methods 0.000 description 21
- 238000012360 testing method Methods 0.000 description 10
- 239000013642 negative control Substances 0.000 description 9
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 210000002798 bone marrow cell Anatomy 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 101100449517 Arabidopsis thaliana GRH1 gene Proteins 0.000 description 6
- 101100434479 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AFB1 gene Proteins 0.000 description 6
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 6
- 229930020125 aflatoxin-B1 Natural products 0.000 description 6
- 229910052785 arsenic Inorganic materials 0.000 description 6
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 6
- 108010028554 LDL Cholesterol Proteins 0.000 description 5
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 5
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 5
- 238000012550 audit Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 208000031404 Chromosome Aberrations Diseases 0.000 description 4
- 231100000111 LD50 Toxicity 0.000 description 4
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 231100000005 chromosome aberration Toxicity 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 229960004844 lovastatin Drugs 0.000 description 4
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- XXKNHBAFFJINCK-RVEJDSBJSA-N monascin Chemical compound C([C@@H]1[C@H](C(O[C@@]1(C)C1=O)=O)C(=O)CCCCC)C2=C1COC(\C=C\C)=C2 XXKNHBAFFJINCK-RVEJDSBJSA-N 0.000 description 4
- GFSMXLMQRWMHON-UHFFFAOYSA-N monascin Natural products CCCCCC(=O)C1C2C=C3C=C(OC=C3C(=O)C2(C)OC1=O)C=CC GFSMXLMQRWMHON-UHFFFAOYSA-N 0.000 description 4
- GIKQHOXMDCDAPT-UHFFFAOYSA-N monascusone B Natural products CC=CC1=CC2=C(CO1)C(=O)C3(C)OC(=O)C(C3C2)C(=O)C GIKQHOXMDCDAPT-UHFFFAOYSA-N 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000021152 breakfast Nutrition 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003471 mutagenic agent Substances 0.000 description 3
- 231100000707 mutagenic chemical Toxicity 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 3
- 235000019710 soybean protein Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- IWDQPCIQCXRBQP-UHFFFAOYSA-M Fenaminosulf Chemical compound [Na+].CN(C)C1=CC=C(N=NS([O-])(=O)=O)C=C1 IWDQPCIQCXRBQP-UHFFFAOYSA-M 0.000 description 2
- 229930183217 Genin Natural products 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000007189 Oryza longistaminata Nutrition 0.000 description 2
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 208000031320 Teratogenesis Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- VWBQYTRBTXKKOG-IYNICTALSA-M pravastatin sodium Chemical compound [Na+].C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC([O-])=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 VWBQYTRBTXKKOG-IYNICTALSA-M 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 229960002855 simvastatin Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- NTDFJPCHHGBHCO-UHFFFAOYSA-N 7,9-dihydro-3H-purine-2,6,8-trione Chemical compound OC1=NC(O)=C2NC(O)=NC2=N1.N1C(=O)NC(=O)C2=C1NC(=O)N2 NTDFJPCHHGBHCO-UHFFFAOYSA-N 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 240000007175 Datura inoxia Species 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000021393 food security Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 208000007357 hyperpituitarism Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229940099246 mevacor Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 229940026314 red yeast rice Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- NCTHNHPAQAVBEB-WGCWOXMQSA-M sodium ferulate Chemical compound [Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O NCTHNHPAQAVBEB-WGCWOXMQSA-M 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 206010061393 typhus Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940072168 zocor Drugs 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Beans For Foods Or Fodder (AREA)
Abstract
Description
检验项目 | 单位 | 2009.01.09 | 2009.05.15 | 参考值 | 2009.06.15 |
胆固醇CHO | mmol/L | 7.31 | 6.98 | 2.8-5.68 | 6.94 |
甘油三酯TG | mmol/L | 1.21 | 0.84 | 0.7-1.71 | 1.0 |
高密度脂蛋白HDL | mmol/L | 1.85 | 1.42 | 1.13-1.76 | 1.40 |
低密度脂蛋白LDL | mmol/L | 4.9 | 3.39 | 1.2-3.12 | 3.27 |
检验项目 | 单位 | 2009-06-20. | 参考值 | 2009-08-06 | 2009-09-06 |
胆固醇CHO | mmol/L | 5.81 | 2.8-5.68 | 5.56 | 5.58 |
甘油三酯TG | mmol/L | 2.32 | 0.56-1.7 | 1.87 | 1.86 |
高密度脂蛋白HDL | mmol/L | 1.26 | 1.13-1.76 | 1.16 | 1.26 |
低密度脂蛋白LDL | mmol/L | 3.79 | 1.2-3.12 | 2.90 | 3.10 |
极低密度VLDL | mmol/L | 1.05 | 0--1 | 0.90 | 0.92 |
检验项目 | 单位 | 2009-07-25 | 参考值 | 2009-09-06 | 2009-10-06 |
胆固醇CHO | mmol/L | 6.4 | 2.8-5.68 | 4.81 | 4.9 |
甘油三酯TG | mmol/L | 1.27 | 0.56-1.7 | 1.5 | 1.56 |
高密度脂蛋白HDL | mmol/L | 1.96 | 1.29-1.55 | 1.35 | 1.42 |
低密度脂蛋白LDL | mmol/L | 3.9 | 1.2-3.12 | 3.22 | 3.24 |
组别 | MN(‰) | CA(%) | 精子畸变率(%) |
阴性对照I | 2.56±0.40 | 1.72±0.32 | 20.78 |
阴性对照II | 2.50±0.37 | 1.68±0.29 | 19.64 |
实验I | 2.46±0.35 | 1.60±0.30 | 19.23 |
实验II | 2.42±0.32 | 1.58±0.26 | 18.89 |
阳性对照 | 16.42±2.84 | 19.15±2.93 | 80.21 |
检测项目 | 大豆预消化食品 | 未发酵大豆 | 安全标准 |
铅Pb(mg/g) | 0.62 | 0.61 | 1 |
砷As(mg/g) | 0.1 | 0.1 | 0.5 |
AFB1(μg/g) | 0.52 | 0.78 | 5 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102107464A CN101695354B (zh) | 2009-11-09 | 2009-11-09 | 一种预消化的大豆食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102107464A CN101695354B (zh) | 2009-11-09 | 2009-11-09 | 一种预消化的大豆食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101695354A true CN101695354A (zh) | 2010-04-21 |
CN101695354B CN101695354B (zh) | 2011-10-19 |
Family
ID=42140513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102107464A Expired - Fee Related CN101695354B (zh) | 2009-11-09 | 2009-11-09 | 一种预消化的大豆食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101695354B (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102197868A (zh) * | 2011-03-28 | 2011-09-28 | 北京御食园食品股份有限公司 | 冻干豆类休闲食品及其制备方法 |
CN102934775A (zh) * | 2012-11-06 | 2013-02-20 | 天津大学 | 基于酶解加工技术的速食整粒黑豆的加工方法 |
CN105192591A (zh) * | 2014-06-30 | 2015-12-30 | 罗汉斐 | 一种黄豆发酵营养食品及其制作方法 |
CN105192590A (zh) * | 2014-06-30 | 2015-12-30 | 罗汉斐 | 一种红豆发酵营养食品及其制作方法 |
CN105192588A (zh) * | 2014-06-30 | 2015-12-30 | 罗汉斐 | 一种无嘌呤黄豆发酵营养食品及其制作方法 |
CN105265894A (zh) * | 2014-06-30 | 2016-01-27 | 罗汉斐 | 一种绿豆发酵营养食品及其制作方法 |
CN105265893A (zh) * | 2014-06-30 | 2016-01-27 | 罗汉斐 | 一种黄豆黑豆发酵营养食品及其制作方法 |
CN105265895A (zh) * | 2014-06-30 | 2016-01-27 | 罗汉斐 | 一种蚕豆发酵营养食品及其制作方法 |
CN105285546A (zh) * | 2014-06-30 | 2016-02-03 | 罗汉斐 | 一种黄豆玉米发酵营养食品及其制作方法 |
CN106306711A (zh) * | 2015-06-29 | 2017-01-11 | 桂林洁宇环保科技有限责任公司 | 有降脂、减肥美体功效又口感好的山楂南瓜黄豆保健食品 |
JP2017109932A (ja) * | 2015-12-14 | 2017-06-22 | 株式会社牛越生理学研究所 | 生理活性物質を含有するクモノスカビ発酵生産物を含む医薬組成物及びその製造方法 |
CN113367345A (zh) * | 2021-06-21 | 2021-09-10 | 付立贤 | 一种预消化食品的生产工艺 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1146487A (zh) * | 1996-07-30 | 1997-04-02 | 陕西省动物研究所 | 大豆稠酒的制作方法 |
CN101019623A (zh) * | 2007-03-30 | 2007-08-22 | 北京王致和食品集团有限公司 | 植物纤维蛋白发酵食品的制作方法 |
CN101423856B (zh) * | 2008-09-28 | 2012-07-04 | 佛山市海天调味食品股份有限公司 | 一种氨基酸多肽营养液、其制备方法及用途 |
-
2009
- 2009-11-09 CN CN2009102107464A patent/CN101695354B/zh not_active Expired - Fee Related
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102197868A (zh) * | 2011-03-28 | 2011-09-28 | 北京御食园食品股份有限公司 | 冻干豆类休闲食品及其制备方法 |
CN102197868B (zh) * | 2011-03-28 | 2013-02-13 | 北京御食园食品股份有限公司 | 冻干豆类休闲食品及其制备方法 |
CN102934775A (zh) * | 2012-11-06 | 2013-02-20 | 天津大学 | 基于酶解加工技术的速食整粒黑豆的加工方法 |
CN102934775B (zh) * | 2012-11-06 | 2014-03-26 | 天津大学 | 基于酶解加工技术的速食整粒黑豆的加工方法 |
CN105192591A (zh) * | 2014-06-30 | 2015-12-30 | 罗汉斐 | 一种黄豆发酵营养食品及其制作方法 |
CN105192590A (zh) * | 2014-06-30 | 2015-12-30 | 罗汉斐 | 一种红豆发酵营养食品及其制作方法 |
CN105192588A (zh) * | 2014-06-30 | 2015-12-30 | 罗汉斐 | 一种无嘌呤黄豆发酵营养食品及其制作方法 |
CN105265894A (zh) * | 2014-06-30 | 2016-01-27 | 罗汉斐 | 一种绿豆发酵营养食品及其制作方法 |
CN105265893A (zh) * | 2014-06-30 | 2016-01-27 | 罗汉斐 | 一种黄豆黑豆发酵营养食品及其制作方法 |
CN105265895A (zh) * | 2014-06-30 | 2016-01-27 | 罗汉斐 | 一种蚕豆发酵营养食品及其制作方法 |
CN105285546A (zh) * | 2014-06-30 | 2016-02-03 | 罗汉斐 | 一种黄豆玉米发酵营养食品及其制作方法 |
CN106306711A (zh) * | 2015-06-29 | 2017-01-11 | 桂林洁宇环保科技有限责任公司 | 有降脂、减肥美体功效又口感好的山楂南瓜黄豆保健食品 |
JP2017109932A (ja) * | 2015-12-14 | 2017-06-22 | 株式会社牛越生理学研究所 | 生理活性物質を含有するクモノスカビ発酵生産物を含む医薬組成物及びその製造方法 |
CN113367345A (zh) * | 2021-06-21 | 2021-09-10 | 付立贤 | 一种预消化食品的生产工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN101695354B (zh) | 2011-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695354B (zh) | 一种预消化的大豆食品 | |
CN101785511B (zh) | 苦荞麦红曲发酵茶的制作方法 | |
KR101315656B1 (ko) | 엽록소가 함유된 미강의 발효추출물 및 그 제조방법 | |
CN105685825A (zh) | 营养混合型杂粮及其制备方法 | |
CN105105110A (zh) | 一种红曲苦荞麦功能性食品的制备方法及其应用 | |
JP4616413B1 (ja) | 発酵食材の製造方法および発酵食品 | |
CN107981324A (zh) | 姜黄发酵食品及其制备方法 | |
CN106798252A (zh) | 一种具有调理肠胃降血脂溶血栓功效的纳豆组方 | |
CN111685264A (zh) | 一种速食燕麦制品及其制备方法 | |
CN103431484A (zh) | 芦笋发酵饮料及其制备方法 | |
CN104784261A (zh) | 肉苁蓉酵素及其制备工艺 | |
CN105614864A (zh) | 一种辣木酵素片及其制备方法 | |
CN110973423A (zh) | 红曲诺丽果饮料及其制备方法 | |
CN101407754A (zh) | 一种黑木耳糙米醋的生产工艺 | |
CN103535576B (zh) | 花粉代餐粉 | |
CN108740891A (zh) | 一种鲊辣椒及其制作方法 | |
KR101192673B1 (ko) | 복합유용발효미생물(fm)을 이용한 혼합곡의 발효 방법 및 대량 생산 방법 | |
CN105520064B (zh) | 一种无添加剂全籽粒绿豆营养主食及其生产方法 | |
KR102168192B1 (ko) | 발효 생약초, 과실류 및 표고를 이용한 건강 혼합차 개발 | |
KR20180109357A (ko) | 발효 닭가슴살을 이용한 저지방 삼계탕의 제조방법 | |
CN106912449A (zh) | 一种富硒肉鸡的饲养方法 | |
KR101847601B1 (ko) | 콩 발효물의 제조 방법, 상기 방법으로 제조된 콩 발효물, 및 이를 포함하는 식품 조성물 | |
CN108740790A (zh) | 一种酱豆及其制作方法 | |
KR101220131B1 (ko) | 효소 현미 및 효소 현미의 제조 방법 | |
CN102559474A (zh) | 一种虫草保健醋的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Zhang Zhengsheng Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice |
Addressee: Zhang Zhengsheng Document name: Notification of Decision on Request for Restoration of Right |
|
DD01 | Delivery of document by public notice |
Addressee: Pan Na Document name: payment instructions |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Zhang Zhengsheng Document name: Notice of termination of patent right |
|
DD01 | Delivery of document by public notice | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111019 Termination date: 20201109 |